Literature DB >> 7691000

Genetic skin diseases caused by mutations in keratin intermediate filaments.

P M Steinert1, S J Bale.   

Abstract

Keratin intermediate filaments are the major differentiation products of epithelial cells such as the epidermis. The filaments are highly dynamic entities involved in the maintenance of the structural integrity of both the individual cells and the entire tissue. Recent biochemical studies suggest that the keratin proteins overlap each other in several key locations when packed together in filaments. Interestingly, mutations that introduce inappropriate amino acid substitutions in at least some of these overlap regions cause defective keratin filaments that result in at least three classes of autosomal dominant skin disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7691000     DOI: 10.1016/0168-9525(93)90014-9

Source DB:  PubMed          Journal:  Trends Genet        ISSN: 0168-9525            Impact factor:   11.639


  10 in total

Review 1.  Implications of intermediate filament protein phosphorylation.

Authors:  N O Ku; J Liao; C F Chou; M B Omary
Journal:  Cancer Metastasis Rev       Date:  1996-12       Impact factor: 9.264

2.  Mutation of human keratin 18 in association with cryptogenic cirrhosis.

Authors:  N O Ku; T L Wright; N A Terrault; R Gish; M B Omary
Journal:  J Clin Invest       Date:  1997-01-01       Impact factor: 14.808

3.  Susceptibility to hepatotoxicity in transgenic mice that express a dominant-negative human keratin 18 mutant.

Authors:  N O Ku; S A Michie; R M Soetikno; E Z Resurreccion; R L Broome; R G Oshima; M B Omary
Journal:  J Clin Invest       Date:  1996-08-15       Impact factor: 14.808

4.  Keratin 8 and 18 mutations are risk factors for developing liver disease of multiple etiologies.

Authors:  Nam-On Ku; Jama M Darling; Sheri M Krams; Carlos O Esquivel; Emmet B Keeffe; Richard K Sibley; Young Moo Lee; Teresa L Wright; M Bishr Omary
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-30       Impact factor: 11.205

5.  Keratin 9 gene mutational heterogeneity in patients with epidermolytic palmoplantar keratoderma.

Authors:  H C Hennies; D Zehender; J Kunze; W Küster; A Reis
Journal:  Hum Genet       Date:  1994-06       Impact factor: 4.132

6.  Genetic mutations in the K1 and K10 genes of patients with epidermolytic hyperkeratosis. Correlation between location and disease severity.

Authors:  A J Syder; Q C Yu; A S Paller; G Giudice; R Pearson; E Fuchs
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

7.  The amino-terminal domain of desmoplakin binds to plakoglobin and clusters desmosomal cadherin-plakoglobin complexes.

Authors:  A P Kowalczyk; E A Bornslaeger; J E Borgwardt; H L Palka; A S Dhaliwal; C M Corcoran; M F Denning; K J Green
Journal:  J Cell Biol       Date:  1997-11-03       Impact factor: 10.539

8.  Dynamics of human keratin 18 phosphorylation: polarized distribution of phosphorylated keratins in simple epithelial tissues.

Authors:  J Liao; L A Lowthert; N O Ku; R Fernandez; M B Omary
Journal:  J Cell Biol       Date:  1995-12       Impact factor: 10.539

9.  Chronic hepatitis, hepatocyte fragility, and increased soluble phosphoglycokeratins in transgenic mice expressing a keratin 18 conserved arginine mutant.

Authors:  N O Ku; S Michie; R G Oshima; M B Omary
Journal:  J Cell Biol       Date:  1995-12       Impact factor: 10.539

10.  Molecular Modeling of Pathogenic Mutations in the Keratin 1B Domain.

Authors:  Alexander J Hinbest; Sherif A Eldirany; Minh Ho; Christopher G Bunick
Journal:  Int J Mol Sci       Date:  2020-09-10       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.